C166 - Neuroimaging Biomarkers Across the Dementia Spectrum

Event Time: Wednesday May 8, 2019 7:00 am to 9:00 am
Topic(s): Aging, Dementia, Cognitive, and Behavioral Neurology
Director(s): Liana Apostolova MD, FAAN
Description: Faculty will update clinicians on the newest vivo methods to detect AD pathology in the brain; review all major modalities for imaging of neurodegenerative disorders and their applications in the clinic and research; discuss barriers to using amyloid radiotracers in the diagnostic evaluation of Alzheimer's and mild cognitive impairment, and ongoing efforts to overcome these barriers; and cover how these new biomarkers can help us understand the heterogeneity of neurodegeneration, and help us improve therapeutic outcomes.
Completion Message: Participants should be able to understand the role imaging methods play in the evaluation of neurodegenerative diseases; gain knowledge of the specific imaging biomarker signatures of the major classes of neurodegenerative diseases; understand how biomarkers can be used in conjunction with clinical findings to refine the differential diagnosis; understand how biomarkers may be used in the future to facilitate targeted therapies; and understand the barriers for using amyloid imaging in clinical settings, and the ongoing approaches to rectify those barriers.
CME Credits: 2
Core Competencies: Patient Care, Medical Knowledge, Practice-Based Learning and Improvement, Systems-Based Practice

Ready to register for the 2019 AAN Annual Meeting?

Register Now

Related Courses